A functional serotonin transporter (SLC6A4) polymorphism modifies the association of smoking and diabetes with asymptomatic carotid atherosclerosis.
Wolff
Birger
B
Grabe
Hans J
HJ
Völzke
Henry
H
Lüdemann
Jan
J
Schwahn
Christian
C
Freyberger
Harald J
HJ
John
Ulrich
U
Lange
Martina
M
Cascorbi
Ingolf
I
Felix
Stephan B
SB
D000368:Aged; D001161:Arteriosclerosis / Q000209:etiology / Q000235:genetics*; D002340:Carotid Artery Diseases / Q000209:etiology / Q000235:genetics*; D048909:Diabetes Complications / Q000235:genetics*; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics*; D026901:Membrane Transport Proteins / Q000235:genetics*; D008875:Middle Aged; D017720:Molecular Epidemiology; D009419:Nerve Tissue Proteins / Q000235:genetics*; D012307:Risk Factors; D050486:Serotonin Plasma Membrane Transport Proteins; D012907:Smoking / Q000009:adverse effects*
D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins